The park is currently in phase two of a master plan that seeks to revitalize all 53 acres of Sarasota's bayfront.
1d
Clinical Trials Arena on MSNCerevance to proceed with Phase III Parkinson’s trial despite Phase II setbackThe pivotal, Phase III study will evaluate the change in average daily “OFF” time in solengepras patients compared to placebo ...
Pembrolizumab plus concurrent chemoradiotherapy shows ongoing antitumor activity after about 5 years of follow-up in patients ...
3d
Clinical Trials Arena on MSNEli Lilly’s lepodisiran cuts lipoprotein(a) by 93.9% in Phase II trialThe Phase II study found that lepodisiran significantly reduced levels of genetically inherited cardiovascular risk factor.
BioSciences announced the first patient has been dosed in the Phase 2 ASCEND study of PCRX-201 for the treatment of ...
Cerevance’s attempt to unlock the first-line Parkinson's disease market has hit a snag, with solengepras performing no better ...
Across the study, two patients experienced “serious adverse events of atrial fibrillation (AF) requiring cardioversion,” ...
Topline Phase 2 clinical data expected in the first half 2025NEW YORK and MELBOURNE, Australia, April 03, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-stage ...
Vaxcyte (PCVX) shared topline results from its Phase 2 dose-finding study evaluating the safety, tolerability and immunogenicity of VAX-24, ...
Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results